New pill plus chemo shows promise for tough head and neck cancers
Disease control
Recruiting now
This phase 2 trial is testing an oral drug called NRC-2694-A combined with the chemotherapy paclitaxel in people with recurrent or metastatic head and neck squamous cell carcinoma that has worsened after immunotherapy. About 21 adults will receive the combination to see if it shr…
Phase: PHASE2 • Sponsor: NATCO Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC